ASH rrMM abstracts that look good - note BMY nivolumab abstract showed 0 ORR from 27 patients in this indication: KPTI Selinexor plus DEX: https://ash.confex.com/ash/2014/webprogram/Paper75658.html Biotest/IMGN BT062 (CD138 ADC) plus LEN/DEX: https://ash.confex.com/ash/2014/webprogram/Paper72016.html SNY/IMGN CD38 SAR plus LEN/DEX: https://ash.confex.com/ash/2014/webprogram/Paper71786.html JNJ/Genmab CD38 Daratumumab: https://ash.confex.com/ash/2014/webprogram/Paper74400.html